Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretin for BAT Activation and Satiation
NCT03290846Phase 3Completed
- Sponsor
- Turku University Hospital
- Start
- Aug 2016
- Primary completion
- Oct 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of secretin in obesity, sponsored by Turku University Hospital. Primary endpoints: Brown Adipose Tissue Glucose Uptake at 1 hour, Brown Adipose Tissue Perfusion at 6 months and 1 more. Started Aug 2016; status: completed.
02
Drugs
secretin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03290846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290846.